Synthesis of New Bioactive Indolyl-1,2,4-Triazole Hybrids As Dual Inhibitors for EGFR/PARP-1 Targeting Breast and Liver Cancer Cells

por Youssef, Mohamed F., Nafie, Mohamed S., Salama, Eid E., Boraei, Ahmed T.A., Gad, Emad M.
Publicado 2022

Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity

por Salem, Manar G., Abu El-ata, Sara A., Elsayed, Elsherbiny H., Mali, Suraj N., Alshwyeh, Hussah Abdullah, Almaimani, Ghassan, Almaimani, Riyad A., Almasmoum, Hussain A., Altwaijry, Najla, Al-Olayan, Ebtesam, Saied, Essa M., Youssef, Mohamed F.
Publicado 2023